Viola Nwachukwu, NP
Psychiatric/Mental Health · Fargo, NDNPI 1649901349
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $928 of the $1,078 with a category attached, or 86.1%. 10 manufacturers reported payments, led by Johnson & Johnson at 54.8% of the total. 2025 is the largest year on record at $510, 4.4 times the $117 reported in 2023.
Across 34 payments — averaging $31.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$591
- H2-pharma, LLC$150
- Teva Pharmaceuticals USA, Inc.$91
- Neurocrine Biosciences, Inc.$62
- Axsome Therapeutics, Inc.$49
- Lundbeck LLC$43
- plus $93 from 4 others
What the payments were for
- Speaking & faculty fees$15014%
- Food & beverage$92886%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $591 |
| H2-pharma, LLC | 1 | $150 |
| Teva Pharmaceuticals USA, Inc. | 6 | $91 |
| Neurocrine Biosciences, Inc. | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $49 |
| Lundbeck LLC | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| AbbVie | 2 | $27 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVEGA SUSTENNA$242
How this compares
$1,078 in reported general payments places this provider in the 85th percentile of 92 psychiatric/mental health providers in North Dakota.
See all psychiatric/mental health providers in North Dakota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 48 | $314,413 |
| RexultiBrexpiprazole | 78 | $94,528 |
| VraylarCariprazine Hcl | 53 | $65,877 |
| Abilify MaintenaAripiprazole | 18 | $51,112 |
| Invega SustennaPaliperidone Palmitate | 14 | $41,136 |
| Paliperidone ErPaliperidone | 39 | $3,987 |
| Lisdexamfetamine Dimesylate | 18 | $3,977 |
| Bupropion XlBupropion Hcl | 241 | $3,898 |
| Aripiprazole | 68 | $3,306 |
| Haloperidol | 13 | $2,381 |
| Olanzapine | 54 | $1,617 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 44 | $1,482 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 85 | $1,253 |
| Gabapentin | 87 | $1,157 |
| Lurasidone Hcl | 27 | $1,023 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $62 | $314,41348 claims |
| AbbVieVraylar | $27 | $65,87753 claims |
| Johnson & JohnsonInvega Sustenna | $591 | $41,13614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 92 psychiatric/mental health providers in North Dakota.
Other psychiatric/mental health in Fargo
- Jessica Graham SteinhauerFargo$8K
- Linda VolnessFargo$2K
- Joanna JohnsonFargo$999
- Leah Victoria HornerFargo$856
- Maryn YoungFargo$822
- Jordyn BuckmierFargo$748
- Erin DiciollaFargo$654
- Ashley CarrFargo$483
- Sarah TerpstraFargo$445
- Erika YoneyFargo$357
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.